Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oklahoma Healthcare Wire.
Press releases published on April 28, 2026
Apr. 28, 2026
Oruka Therapeutics Announces Pricing of Upsized $700 Million Underwritten Public Offering
Indeterminate
GlobeNewswire
Apr. 28, 2026
ARCPOINT ANNOUNCES RESIGNATION OF BOARD MEMBER
Indeterminate
GlobeNewswire
Apr. 28, 2026
KFSH premia a los ganadores de Innovation Challenge en C3 Davos of Healthcare™ Silicon Valley Summit
Indeterminate
GlobeNewswire
Apr. 28, 2026
Vencedores do Desafio da Inovação do Prêmio KFSH na C3 Davos of Healthcare™ Silicon Valley Summit
Indeterminate
GlobeNewswire
Apr. 28, 2026
Dr. Petros Kotsidis: KFSH Posiciona a IA como Modelo Escalável para a Inovação na Saúde no Mundo Real
Indeterminate
GlobeNewswire
Apr. 28, 2026
Organogenesis Completes Rolling Submission of Biologics License Application for ReNu®
Indeterminate
GlobeNewswire
Apr. 28, 2026
Pacira BioSciences Files Definitive Proxy Materials and Mails Letter to Shareholders
Indeterminate
GlobeNewswire
Apr. 28, 2026
Spectral AI Schedules 2026 First Quarter Financial Results and Conference Call
Indeterminate
GlobeNewswire
Apr. 28, 2026
Bioventus to Report First Quarter of Fiscal Year 2026 Financial Results on May 6, 2026
Indeterminate
GlobeNewswire
Apr. 28, 2026
Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026
Indeterminate
GlobeNewswire
Apr. 28, 2026
Nyxoah Publiera ses Résultats Financiers du Premier Trimestre 2026 le 12 Mai 2026
Indeterminate
GlobeNewswire
Apr. 28, 2026
Myriad Genetics to Release First Quarter 2026 Financial Results on May 5, 2026
Indeterminate
GlobeNewswire
Apr. 28, 2026
Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Apr. 28, 2026
OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results
Indeterminate
GlobeNewswire